Sanofi raided by EU in flu vaccines antitrust probe, FT reports

Sanofi (SNY) is being investigated by European antitrust regulators over potentially anti-competitive behavior, The Financial Times’ Hannah Kuchler and Barbara Moens report. In a statement, the European Commission says it had raided a company in the vaccines sector because it had “concerns that the inspected company may have violated EU antitrust rules that prohibit abuses of a dominant market position,” noting “exclusionary practices that may amount to anti-competitive disparagement.” Sanofi confirmed that representatives of the commission visited its premises in France and Germany on Monday, “in connection with an investigation into conduct in the seasonal flu vaccine space.”